Molecular Medicine Israel

Category: General Health

Neutralizing HIV

Broadly neutralizing antibodies, those that could squash a wide swath of virus types, are the supreme goal of HIV vaccine development. Although some people infected

Read More »

Clinical Matchmaker

In late 2011, the outlook for AstraZeneca’s cancer drug Lynparza (olaparib) was grim. After an interim analysis revealed disappointing results in a Phase 2 trial,

Read More »

Evolutionary Rewiring

Bacteria that lack a vital protein for growing flagella—tail-like structures that enable the microbes to swim—can attain flagella in as little as four days given

Read More »